We use cookies for certain features and to improve your experience. See our Cookie Policy and Privacy Policy to learn more

Leafly

Shop legal, local weed.

Open
advertise on Leafly
ShopDeliveryDispensariesDealsStrainsBrandsProductsLeafly PicksCBDDoctorsCannabis 101Social impact
  • Sign in
  • Create account
  • Strains
  • Shop
  • Shop
  • Delivery
  • Deals
  • Dispensaries
  • CBD Stores
  • Brands
  • Products
  • Leafly Picks
  • Learn
  • Cannabis 101
  • News
  • Leafly Learn
  • Science of cannabis
  • Doctors
  • Social impact
  • Lab partners
  • Download the Leafly App
  • Advertise on Leafly
    • Leafly.comUSA flag
    • Leafly.caCanadian flag
  • Help
  1. Home
  2. News
  3. Industry
  4. MassRoots Note Default Raises Questions About Company’s Future
  • News
  • Cannabis 101
  • Growing
  • Strains & products
  • CBD
  • Politics
  • Health
  • Lifestyle
  • Science & tech
  • Industry
  • Reports
  • Canada
  • Podcasts
  • Leafly Lists
Industry

MassRoots Note Default Raises Questions About Company’s Future

Leafly StaffLast updated July 28, 2020
(Julia Sumpter/Leafly)

Is MassRoots in a temporary cash-flow pinch, or is the company in deeper trouble?

The CEO of the cannabis-focused social network told investors yesterday that the company is “in a stronger position than ever,” but a number of recent Securities and Exchange Commission (SEC) filings have raised questions about financial situation of the Denver-based company.

As first reported Tuesday morning in Business Den, the Denver business news website, MassRoots notified the SEC on Sept. 21 that the company had defaulted on a $1.5 million promissory note. When the six-month convertible note, issued in March, came due Sept. 14, the company was unable to make the required payments, it said.

A promissory note is a simple type of loan sometimes used by companies to bridge a temporary financial shortfall. Investor A gives money to Company B, and Company B agrees to repay the money by a specified date. It’s a legally binding IOU, essentially.

MassRoots has raised more than $5 million in capital investments since 2013, and made headlines as “The First Weed Tech IPO” when it went public at $7 per share in April 2015. The company’s stock currently trades on the over-the-counter market at around 50 cents per share under the ticker MSRT. In April of this year, the company applied to become the first cannabis-related stock listed on the NASDAQ. The exchange ultimately rejected that request.

Yesterday, five days after notifying the SEC about the note default, MassRoots Chairman and CEO Isaac Dietrich issued a letter to the company’s investors. Dietrich gave an upbeat overview of the company’s financials, and reported excellent second quarter results: “we generated more revenue in a single quarter than in all previous quarters combined.” Since July, Dietrich wrote, MassRoots has eliminated 14 of its 33 full-time employees and cut $146,000 in monthly expenses. The company recently partnered with the cannabis business intelligence firm Headset to develop business data products.

An earnings report filed by MassRoots earlier this year disclosed that $320,000 in advertising contracts were signed during the first quarter of 2016, the Business Den report noted.

Dietrich’s letter issued Monday made no mention of the promissory note default. The CEO assured investors that “MassRoots is in a stronger position than ever while the 2016 elections have the potential to significantly accelerate the growth of the cannabis market.”

Leafly reached out to MassRoots earlier today for reaction to the recent SEC filings. The company’s spokesperson declined to comment further.

Banking and Investing

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • See all dispensaries
See all dispensaries
financeIndustryMassRootssocial media
Leafly Staff
Leafly Staff
Leafly is the world’s largest cannabis information resource, empowering people in legal cannabis markets to learn about the right products for their lifestyle and wellness needs. Our team of cannabis professionals collectively share years of experience in all corners of the market, from growing and retail, to science and medicine, to data and technology.
View Leafly Staff's articles

The latest in Industry

  • Hemp access isn’t done yet: What you need to know about the federal government’s impending ban image
    Hemp access isn’t done yet: What you need to know about the federal government’s impending ban
    Morgan Rosendale
  • URB’N Dispensary: From pharmacist to cannabist image
    URB’N Dispensary: From pharmacist to cannabist
    Leafly Staff
  • Happy Eddie: From reality TV to real-life cannabis reform image
    Happy Eddie: From reality TV to real-life cannabis reform
    Leafly Staff
  • Delaware is open for business: Here’s where to buy legal weed image
    Delaware is open for business: Here’s where to buy legal weed
    Leafly Staff
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

Something went wrong, please try again.

By providing us with your email address, you agree to Leafly’s Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App StoreDownload Leafly Marijuana Reviews on Google Play

Business Solutions
  • List your store
  • List your CBD store
  • List your brand
  • List your practice
  • Business log in

About Leafly
  • About us
  • Careers
  • Newsroom
  • Investor relations
  • Contact us
  • FAQs
  • Accessibility

Dispensaries in
  • Los Angeles
  • Seattle
  • Portland
  • San Francisco
  • Toronto
  • Detroit

Privacy & Terms
  • Terms of use
  • Commercial terms of use
  • Privacy policy
  • Do not sell my personal information

* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.


© 2025 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.